These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 167553)

  • 21. [Hypophosphatasia: new therapeutic approaches].
    Alonso G; Varsavsky M; Muñoz-Torres M
    Med Clin (Barc); 2009 Jan; 132(3):108-11. PubMed ID: 19211064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrophosphate in synovial fluid and urine and its relationship to urinary risk factors for stone disease.
    Roberts NB; Dutton J; Helliwell T; Rothwell PJ; Kavanagh JP
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():529-34. PubMed ID: 1332571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inorganic pyrophosphate in metabolic diseases predisposing to calcium pyrophosphate dihydrate crystal deposition.
    Doherty M; Chuck A; Hosking D; Hamilton E
    Arthritis Rheum; 1991 Oct; 34(10):1297-303. PubMed ID: 1657004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary pyrophosphate in patients with recurrent calcium urolithiasis and in healthy controls: a re-evaluation.
    Schwille PO; Rümenapf G; Wölfel G; Köhler R
    J Urol; 1988 Aug; 140(2):239-45. PubMed ID: 2840520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult hypophosphatasia treated with teriparatide.
    Whyte MP; Mumm S; Deal C
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1203-8. PubMed ID: 17213282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First Reported Case of a Pyrophosphate Kidney Stone in a Human.
    Gigax MR; Yang L; Austin G; Mandel NS; Lulich JP; Asplin JR
    Case Rep Nephrol Dial; 2023; 13(1):135-141. PubMed ID: 37900931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies in hypophosphatasia and response to high phosphate intake.
    Bongiovanni AM; Album MM; Root AW; Hope JW; Marino J; Spencer DM
    Am J Med Sci; 1968 Mar; 255():163-70. PubMed ID: 4296178
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversible Deterioration in Hypophosphatasia Caused by Renal Failure With Bisphosphonate Treatment.
    Cundy T; Michigami T; Tachikawa K; Dray M; Collins JF; Paschalis EP; Gamsjaeger S; Roschger A; Fratzl-Zelman N; Roschger P; Klaushofer K
    J Bone Miner Res; 2015 Sep; 30(9):1726-37. PubMed ID: 25736332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of alkaline phosphatase in the serum proteins in hypophosphatasia.
    KORNER NH
    J Clin Pathol; 1962 May; 15(3):200-5. PubMed ID: 14458464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrophosphate arthropathy in hypophosphatasia.
    Eade AW; Swannell AJ; Williamson N
    Ann Rheum Dis; 1981 Apr; 40(2):164-70. PubMed ID: 6261701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary pyrophosphate in normal subjects and in stone formers.
    O'Brien MM; Uhlemann I; McIntosh HW
    Can Med Assoc J; 1967 Jan; 96(2):100-3. PubMed ID: 4289320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of phosphorus compounds in tissues and cultured skin fibroblasts in patients with hypophosphatasia.
    Eto Y; Tada Y
    Biochem Biophys Res Commun; 1988 Aug; 154(3):948-53. PubMed ID: 3408505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of sustained response to teriparatide in a patient with adult hypophosphatasia.
    Gagnon C; Sims NA; Mumm S; McAuley SA; Jung C; Poulton IJ; Ng KW; Ebeling PR
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1007-12. PubMed ID: 20089612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of 99mTc-labeled pyrophosphate and polyphosphate in man.
    Krishnamurthy GT; Huebotter RJ; Walsh CF; Taylor JR; Kehr MD; Tubis M; Blahd WH
    J Nucl Med; 1975 Feb; 16(2):109-15. PubMed ID: 162949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy.
    Akiyama T; Kubota T; Ozono K; Michigami T; Kobayashi D; Takeyari S; Sugiyama Y; Noda M; Harada D; Namba N; Suzuki A; Utoyama M; Kitanaka S; Uematsu M; Mitani Y; Matsunami K; Takishima S; Ogawa E; Kobayashi K
    Mol Genet Metab; 2018 Sep; 125(1-2):174-180. PubMed ID: 30049651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult hypophosphatasia and a low level of red blood cell thiamine pyrophosphate.
    Luong KV; Nguyen LT
    Ann Nutr Metab; 2005; 49(2):107-9. PubMed ID: 15802905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and laboratory studies of severe periodontal disease in an adolescent associated with hypophosphatasia. A case report.
    Watanabe H; Umeda M; Seki T; Ishikawa I
    J Periodontol; 1993 Mar; 64(3):174-80. PubMed ID: 8385214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
    Bowden SA; Adler BH
    Osteoporos Int; 2018 Feb; 29(2):511-515. PubMed ID: 29046930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypophosphatasia (adult form): quantitation of serum alkaline phosphatase isoenzyme activity in a large kindred.
    Millán JL; Whyte MP; Avioli LV; Fishman WH
    Clin Chem; 1980 Jun; 26(7):840-5. PubMed ID: 7379306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.
    Whyte MP; Coburn SP; Ryan LM; Ericson KL; Zhang F
    Bone; 2018 May; 110():96-106. PubMed ID: 29360619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.